Literature DB >> 23922000

Who is now responsible for discovering and warning about adverse effects of generic drugs?

Aaron S Kesselheim1, Michael D Green, Jerry Avorn.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23922000     DOI： 10.1001/jama.2013.228349

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland.

Authors:  A O'Leary; C Usher; M Lynch; M Hall; L Hemeryk; S Spillane; P Gallagher; M Barry
Journal:  BMC Res Notes       Date:  2015-12-15

2.  Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents.

Authors:  Victoria R Cornelius; Kun Liu; Janet Peacock; Odile Sauzet
Journal:  BMJ Open       Date:  2016-03-20       Impact factor: 2.692

Review 3.  Phase 4 Studies in Heart Failure - What is Done and What is Needed?

Authors:  Pupalan Iyngkaran; Danny Liew; Peter McDonald; Merlin C Thomas; Christopher Reid; Derek Chew; David L Hare
Journal:  Curr Cardiol Rev       Date:  2016
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.